Multivalent Tau/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density

Zheng Shen1, Daxiao Sun2, Adriana Savastano1

  • 1German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.

Nature Communications
|October 27, 2023
PubMed

Insights

Microtubule-associated protein Tau arrests postsynaptic protein clusters, contributing to cognitive decline in Alzheimer's disease. This Tau interaction with PSD-95 protein pockets reveals a novel molecular mechanism impacting synaptic function.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is characterized by progressive memory loss and cognitive impairment.
  • Postsynaptic localization of microtubule-associated protein Tau (Tau) is linked to cognitive deficits in AD.
  • The precise role of Tau in postsynaptic dysfunction remains incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Tau influences postsynaptic protein dynamics.
  • To investigate the interaction between Tau and key postsynaptic density (PSD) proteins.
  • To explore potential therapeutic targets for modulating Tau-mediated synaptic dysfunction.

Main Methods:

  • In vitro studies using purified proteins to assess Tau's effect on liquid-like protein droplets.
  • Biophysical techniques to analyze Tau binding to PSD-95.
  • Experiments with synthetic membranes to model NMDA receptor clusters.
  • Investigating the impact of competitive peptide binding on protein dynamics.

Main Results:

  • Tau was shown to arrest liquid-like droplets of PSD-95, GKAP, Shank, and Homer proteins.
  • Tau binding to the GMP-binding pocket of PSD-95 was identified as crucial for this arrest.
  • Tau-mediated arrest of NMDA-receptor-associated protein clusters on synthetic membranes was observed.
  • Competitive binding of a phosphorylated peptide to PSD-95 rescued the dynamics of NMDA receptor constructs.

Conclusions:

  • Tau modulates the dynamic properties of the postsynaptic density by arresting protein clusters.
  • This Tau-mediated arrest mechanism offers a new perspective on synaptic dysfunction in Alzheimer's disease.
  • Targeting the Tau-PSD-95 interaction may represent a therapeutic strategy for AD.

Related Concept Videos